Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

Int J Urol. 2019 Mar;26(3):426-428. doi: 10.1111/iju.13870. Epub 2018 Nov 21.

Authors

Masaki Shiota¹, Ryo Namitome¹, Takeshi Kobayashi¹, Junichi Inokuchi¹, Katsunori Tatsugami¹, Masatoshi Eto¹

Affiliation

¹ Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

PMID: 30461081
DOI: 10.1111/iju.13870

No abstract available

MeSH terms

Aged
Androgen Antagonists / administration & dosage*
Androstenes / administration & dosage
Antineoplastic Agents / administration & dosage*
Biopsy, Large-Core Needle
Clinical Trials as Topic
Disease Progression
Docetaxel / administration & dosage
Humans
Japan
Male
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Recurrence, Local / epidemiology
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / prevention & control
Orchiectomy
Prognosis
Progression-Free Survival
Prostate / pathology
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / mortality
Prostatic Neoplasms / pathology
Prostatic Neoplasms / therapy*
Retrospective Studies
Risk Assessment / methods

Substances

Androgen Antagonists
Androstenes
Antineoplastic Agents
Docetaxel
abiraterone